Scroll Top

Tag: Dr. Schär

FY 2025: Dr. Schär invests EUR 8.8 million in efficiency optimization

Dr. Schär closed FY 2025 with global sales of EUR 632 million. This represents an increase of 1.3% compared to 2024 (EUR 624 million). EUR 8.8 million was invested in improving the efficiency of production and logistics. A further EUR 28 million is planned for 2026 to expand production capacities in Italy, Spain, and Germany.

Semper sells Nordic gluten-free business to Dr. Schär

Semper, a Hero Group company, announced the sale of its gluten-free business in the Nordics to Dr. Schär. The company plans to focus its business on its core categories – children’s food and healthy snacks.